Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

NCT06311032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2024-03-15

No results posted yet for this study

Summary

The main objective of this study is to determine how physicians make decisions regarding surveillance of Intraductal Papillary Mucinous Neoplasm's (IPMN) of the pancreas.

Conditions

  • Surgery Risk Assessment

Sponsors & Collaborators

Principal Investigators

  • Greg Sacks, MD, MPH, PhD · NYU Langone Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-29
Primary Completion
2023-06-28
Completion
2023-07-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06311032 on ClinicalTrials.gov